Cadherin-13 in primary and blast crisis chronic myeloid leukaemia: declining expression and negative correlation with the BCR/ABL fusion gene

Abstract Expression of the CDH13 gene in chronic myeloid leukaemia (CML) patients at different clinical stages, and its relationship with the BCR/ABL fusion gene, is investigated. Expression of the CDH13 gene and the BCR/ABL fuse gene is investigated in peripheral blood from 30 healthy adults, 25 primary CML patients and 25 CML patients in blast crisis using the EvaGreen real-time reverse transcriptase polymerase chain reaction (RT-PCR). Results showed that BCR/ABL fusion gene expression in the blast crisis CML patients was 4.72-fold higher than that in patients with primary CML. Expression of CDH13 mRNA in primary and blast crisis CML patients was lower than in the healthy adults, reduced 64% and 75%, respectively. Expression of CDH13 showed a negative correlation with the BCR/ABL fusion gene. The data indicate that the decline of CDH13 expression accompanied the different clinical stages of CML and probably was involved in over-expression of the BCR/ABL fusion gene.

[1]  M. Greaves,et al.  Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.

[2]  B. Ranscht,et al.  Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium- dependent, homophilic cell adhesion , 1992, The Journal of cell biology.

[3]  C. Verfaillie,et al.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. , 1994, The Journal of clinical investigation.

[4]  Sam W. Lee.  H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer , 1996, Nature Medicine.

[5]  R. Bhatia,et al.  The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia. , 1998, Leukemia & lymphoma.

[6]  R. Bhatia,et al.  Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. , 1998, Blood.

[7]  R. Bhatia,et al.  Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. , 1999, Experimental hematology.

[8]  M. Sato,et al.  Chromosome band 16q24 is frequently deleted in human gastric cancer , 1999, British Journal of Cancer.

[9]  L. Hartmann,et al.  Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. , 1999, International journal of oncology.

[10]  E. Andreu,et al.  Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL , 2000, The Journal of experimental medicine.

[11]  V. Moreno,et al.  L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. , 2000, Haematologica.

[12]  K. Akashi,et al.  Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. , 2001, Blood.

[13]  B. Angst,et al.  COMMENTARY The cadherin superfamily: diversity in form and function , 2022 .

[14]  R. Perez-soler,et al.  Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  J. Bourhis,et al.  BCR-ABL down-regulates the DNA repair protein DNA-PKcs. , 2001, Blood.

[16]  J. Minna,et al.  Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. , 2001, Cancer research.

[17]  Matthew B. Wilson,et al.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells , 2002, The EMBO journal.

[18]  S. Minucci,et al.  Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.

[19]  S. Toyooka,et al.  Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. , 2002, Cancer research.

[20]  M. Caligiuri,et al.  BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. , 2002, Nature genetics.

[21]  H. Iwasaki,et al.  Critical role for Gab2 in transformation by BCR/ABL. , 2002, Cancer cell.

[22]  P. Paschka,et al.  Imatinib restores expression of CD62L in BCR‐ABL‐positive cells , 2003, Journal of leukocyte biology.

[23]  T. Ueda,et al.  Expression of the antiapoptotic gene survivin in chronic myeloid leukemia. , 2003, Anticancer Research.

[24]  A. Grañena,et al.  Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Eric Deutsch,et al.  Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. , 2003, Blood.

[26]  D. Gutmann,et al.  T-Cadherin-Mediated Cell Growth Regulation Involves G2 Phase Arrest and Requires p21CIP1/WAF1 Expression , 2003, Molecular and Cellular Biology.

[27]  S. Minucci,et al.  Epigenetic gene silencing in acute promyelocytic leukemia. , 2004, Biochemical pharmacology.

[28]  P. Pelicci,et al.  Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo , 2005, Oncogene.

[29]  J. Melo,et al.  Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia , 2005, Oncogene.

[30]  C. Bueso-Ramos,et al.  New insights into the pathobiology and treatment of chronic myelogenous leukemia. , 2007, Annals of diagnostic pathology.

[31]  A. Utani,et al.  T‐cadherin enhances cell–matrix adhesiveness by regulating β1 integrin trafficking in cutaneous squamous carcinoma cells , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[32]  Z. Modrušan,et al.  Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. , 2007, Differentiation; research in biological diversity.